Healthy Live Births Should be Considered as Competing Events when Estimating the Total Effect of Prenatal Medication Use on Pregnancy Outcomes
Authors:
Preprint
Abstract
Pregnancy loss is recognized as an important competing event in studies of prenatal medication use. However, a healthy live birth also precludes subsequent adverse pregnancy outcomes, yet these events are often censored. Using Monte Carlo simulation, we examine bias that results from failure to account for healthy live birth as a competing event in estimates of the total effect of prenatal medication use on pregnancy outcomes. We simulated data for 12 trials estimating the effect of antihypertensive initiation versus non-initiation on two outcomes: (1) composite fetal death or severe prenatal preeclampsia and (2) small-for-gestational-age (SGA) live birth. We used time-to-event methods to estimate absolute risks, risk differences and risk ratios. For the composite outcome, we conducted two analyses where non-preeclamptic live birth was (1) a censoring event and (2) a competing event. For SGA live birth, we conducted three analyses where fetal death and non-SGA live birth were (1) censoring events, (2) a competing event and censoring event, respectively; and (3) competing events. In all analyses, censoring healthy live births led to inflated absolute risk estimates as well as bias and imprecise treatment effect estimates. Studies of prenatal exposures on pregnancy outcomes should analyze healthy live births as competing risks to estimate unbiased total treatment effects.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Causal Inference in the Face of Competing EventsCurrent Epidemiology Reports, 2020
- A causal framework for classical statistical estimands in failure‐time settings with competing eventsStatistics in Medicine, 2020
- Use of real‐world evidence from healthcare utilization data to evaluate drug safety during pregnancyPharmacoepidemiology and Drug Safety, 2019
- Multistate methodology improves risk assessment under time‐varying drug intake—a new view on pregnancy outcomes following coumarin exposurePharmacoepidemiology and Drug Safety, 2019
- Using simulation studies to evaluate statistical methodsStatistics in Medicine, 2019
- The Curse of the Perinatal Epidemiologist: Inferring Causation Amidst SelectionCurrent Epidemiology Reports, 2018
- Bias from restricting to live births when estimating effects of prescription drug use on pregnancy complications: A simulationPharmacoepidemiology and Drug Safety, 2018
- Methodologic Issues when Estimating Risks in PharmacoepidemiologyCurrent Epidemiology Reports, 2016
- Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset diseaseAmerican Journal of Obstetrics and Gynecology, 2013
- Assessing the effect of vaccine on spontaneous abortion using time‐dependent covariates Cox modelsPharmacoepidemiology and Drug Safety, 2012